199 related articles for article (PubMed ID: 36902728)
1. Th2 Cytokines Affect the Innate Immune Barrier without Impairing the Physical Barrier in a 3D Model of Normal Human Skin.
Donetti E; Riva F; Indino S; Lombardo G; Baruffaldi Preis F; Rosi E; Prignano F
J Clin Med; 2023 Mar; 12(5):. PubMed ID: 36902728
[TBL] [Abstract][Full Text] [Related]
2. Influence of Th2 Cytokines on the Cornified Envelope, Tight Junction Proteins, and ß-Defensins in Filaggrin-Deficient Skin Equivalents.
Hönzke S; Wallmeyer L; Ostrowski A; Radbruch M; Mundhenk L; Schäfer-Korting M; Hedtrich S
J Invest Dermatol; 2016 Mar; 136(3):631-639. PubMed ID: 27015451
[TBL] [Abstract][Full Text] [Related]
3.
Oh JS; Lee SJ; Choung SY
Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579088
[TBL] [Abstract][Full Text] [Related]
4. Antagonistic Effects of IL-4 on IL-17A-Mediated Enhancement of Epidermal Tight Junction Function.
Brewer MG; Yoshida T; Kuo FI; Fridy S; Beck LA; De Benedetto A
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31438472
[TBL] [Abstract][Full Text] [Related]
5. Impaired Tight Junctions in Atopic Dermatitis Skin and in a Skin-Equivalent Model Treated with Interleukin-17.
Yuki T; Tobiishi M; Kusaka-Kikushima A; Ota Y; Tokura Y
PLoS One; 2016; 11(9):e0161759. PubMed ID: 27588419
[TBL] [Abstract][Full Text] [Related]
6. Profile of skin barrier proteins (filaggrin, claudins 1 and 4) and Th1/Th2/Th17 cytokines in adults with atopic dermatitis.
Batista DI; Perez L; Orfali RL; Zaniboni MC; Samorano LP; Pereira NV; Sotto MN; Ishizaki AS; Oliveira LM; Sato MN; Aoki V
J Eur Acad Dermatol Venereol; 2015 Jun; 29(6):1091-5. PubMed ID: 25271795
[TBL] [Abstract][Full Text] [Related]
7. Type 2 Inflammation Contributes to Skin Barrier Dysfunction in Atopic Dermatitis.
Beck LA; Cork MJ; Amagai M; De Benedetto A; Kabashima K; Hamilton JD; Rossi AB
JID Innov; 2022 Sep; 2(5):100131. PubMed ID: 36059592
[TBL] [Abstract][Full Text] [Related]
8. Activation of epidermal toll-like receptor 2 enhances tight junction function: implications for atopic dermatitis and skin barrier repair.
Kuo IH; Carpenter-Mendini A; Yoshida T; McGirt LY; Ivanov AI; Barnes KC; Gallo RL; Borkowski AW; Yamasaki K; Leung DY; Georas SN; De Benedetto A; Beck LA
J Invest Dermatol; 2013 Apr; 133(4):988-98. PubMed ID: 23223142
[TBL] [Abstract][Full Text] [Related]
9. Herpes Simplex Virus 1 Can Bypass Impaired Epidermal Barriers upon
Möckel M; De La Cruz NC; Rübsam M; Wirtz L; Tantcheva-Poor I; Malter W; Zinser M; Bieber T; Knebel-Mörsdorf D
J Virol; 2022 Sep; 96(17):e0086422. PubMed ID: 35969080
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-4 and interleukin-13 compromise the sinonasal epithelial barrier and perturb intercellular junction protein expression.
Wise SK; Laury AM; Katz EH; Den Beste KA; Parkos CA; Nusrat A
Int Forum Allergy Rhinol; 2014 May; 4(5):361-70. PubMed ID: 24510479
[TBL] [Abstract][Full Text] [Related]
11. Deacetylasperulosidic Acid Ameliorates Pruritus, Immune Imbalance, and Skin Barrier Dysfunction in 2,4-Dinitrochlorobenzene-Induced Atopic Dermatitis NC/Nga Mice.
Oh JS; Seong GS; Kim YD; Choung SY
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008651
[TBL] [Abstract][Full Text] [Related]
12. TSLP Impairs Epidermal Barrier Integrity by Stimulating the Formation of Nuclear IL-33/Phosphorylated STAT3 Complex in Human Keratinocytes.
Dai X; Muto J; Shiraishi K; Utsunomiya R; Mori H; Murakami M; Sayama K
J Invest Dermatol; 2022 Aug; 142(8):2100-2108.e5. PubMed ID: 35065132
[TBL] [Abstract][Full Text] [Related]
13. TNF-α and Th2 cytokines induce atopic dermatitis-like features on epidermal differentiation proteins and stratum corneum lipids in human skin equivalents.
Danso MO; van Drongelen V; Mulder A; van Esch J; Scott H; van Smeden J; El Ghalbzouri A; Bouwstra JA
J Invest Dermatol; 2014 Jul; 134(7):1941-1950. PubMed ID: 24518171
[TBL] [Abstract][Full Text] [Related]
14. Epidermal tight junctions in health and disease.
Brandner JM; Zorn-Kruppa M; Yoshida T; Moll I; Beck LA; De Benedetto A
Tissue Barriers; 2015; 3(1-2):e974451. PubMed ID: 25838981
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptor 2 ligands promote chronic atopic dermatitis through IL-4-mediated suppression of IL-10.
Kaesler S; Volz T; Skabytska Y; Köberle M; Hein U; Chen KM; Guenova E; Wölbing F; Röcken M; Biedermann T
J Allergy Clin Immunol; 2014 Jul; 134(1):92-9. PubMed ID: 24698321
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-143 inhibits IL-13-induced dysregulation of the epidermal barrier-related proteins in skin keratinocytes via targeting to IL-13Rα1.
Zeng YP; Nguyen GH; Jin HZ
Mol Cell Biochem; 2016 May; 416(1-2):63-70. PubMed ID: 27048505
[TBL] [Abstract][Full Text] [Related]
17. Topical Glucose Induces Claudin-1 and Filaggrin Expression in a Mouse Model of Atopic Dermatitis and in Keratinocyte Culture, Exerting Anti-inflammatory Effects by Repairing Skin Barrier Function.
Yamada K; Matsushita K; Wang J; Kanekura T
Acta Derm Venereol; 2018 Jan; 98(1):19-25. PubMed ID: 28967978
[TBL] [Abstract][Full Text] [Related]
18. Fermented
Kim SH; Seong GS; Choung SY
Nutrients; 2020 Jan; 12(1):. PubMed ID: 31963703
[No Abstract] [Full Text] [Related]
19. Epidermal barrier reaction to an in vitro psoriatic microenvironment.
Donetti E; Cornaghi L; Arnaboldi F; Ricceri F; Pescitelli L; Maiocchi M; Carriero F; Baruffaldi Preis F; Prignano F
Exp Cell Res; 2017 Nov; 360(2):180-188. PubMed ID: 28890293
[TBL] [Abstract][Full Text] [Related]
20. Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes.
Nomura I; Goleva E; Howell MD; Hamid QA; Ong PY; Hall CF; Darst MA; Gao B; Boguniewicz M; Travers JB; Leung DY
J Immunol; 2003 Sep; 171(6):3262-9. PubMed ID: 12960356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
